Lung cancer drug resistance explained by computer simulations
Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Research; Faculty of Science, Faculty of Science, School of Chemistry; Press Release Source Type: news
More News: Cancer | Cancer & Oncology | Chemistry | Computers | Italy Health | Lung Cancer | Science | Universities